St George's Hospital Medical School (2020) Treatment of fibrosis With RAF inhibitors. WO 2020/161477.

Preview	Text - Published Version · Please see our End User Agreement before downloading. 6MB
Preview	Text (Patent specification as filed) - Accepted Version · Please see our End User Agreement before downloading. 6MB
Preview	Image (Figures to go with patent specification) - Supplemental Material · Please see our End User Agreement before downloading. 7MB
Preview	Text (Publication notice) - Other · Please see our End User Agreement before downloading. 46kB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Download Statistics

Download Statistics

Download Statistics

Downloads

Downloads per month over past year

Funded Project

Funded Project

Funded Project

Funders:	British Heart Foundation	The sponsoring bodies who contributed funding for the creation of this item. Example: NERC Example: The Royal Society of Chemistry A pick list of funders may appear as you type in the funder's name in full or as an acronym. Select a correct match to complete the field or type in a new entry in full. For new entries, the full name is preferred.
Projects:	The role of BRaf in the heart and cardiac effects vemurafenib, dabrafenib and trametinib, recently licensed cancer therapies that target BRaf and MKK1/2 Funded by: British Heart Foundation (PG/13/71/30460 - £262,981) Local Lead (PI): Angela Clerk 1 March 2014 - 28 February 2017	Click Add to select your project (received at Reading) from an autocomplete list.

Deposit Details

Deposit Details

Deposit Details

Date Deposited:	12 Jan 2021 23:40	Date item deposited into CentAUR
Last Modified:	28 Jul 2023 07:38	Date item last modified

University Staff: Request a correction | Centaur Editors: Update this record